XML 78 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity and Share-Based Compensation (Tables)
 12 Months Ended
Dec. 29, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Dividends Declared
Through December 29, 2013, the Company’s Board of Directors declared the following dividends:
Declaration Date
 
Dividend per Share
 
Record Date
 
Total Amount Declared
 
Payment Date
   
 
   
 
   
 
(In millions)
 
 
July 30, 2013
 
$
0.225

 
August 12, 2013
 
$
51.6

 
August 30, 2013
October 15, 2013
 
0.225

 
November 4, 2013
 
51.5

 
November 25, 2013
Fair value of stock options granted to employees, officers and non-employee board members and ESPP shares granted to employees
The fair value of the Company’s stock options granted, excluding unvested stock options assumed through acquisitions, was estimated using the following weighted average assumptions:
 
Fiscal years ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Dividend yield
0% - 1.63%
 
—%
 
—%
Expected volatility
0.37
 
0.43
 
0.43
Risk-free interest rate
0.74%
 
0.60%
 
1.49%
Expected term
4.4 years
 
4.3 years
 
4.3 years
Estimated annual forfeiture rate
8.51%
 
8.59%
 
8.57%
Weighted average fair value at grant date
$16.26
 
$16.45
 
$17.37
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions
The fair value of the Company’s ESPP shares for plans entered into during the fiscal year was estimated using the following weighted average assumptions:
 
Fiscal years ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Dividend yield
0% - 1.63%
 
—%
 
—%
Expected volatility
0.34
 
0.41
 
0.43
Risk-free interest rate
0.11%
 
0.15%
 
0.13%
Expected term
½ year
 
½ year
 
½ year
Weighted average fair value at purchase date
$13.08
 
$11.87
 
$12.17
Stock options and stock appreciation rights
A summary of stock option and stock appreciation rights (“SARs”) activity under all of the Company’s share-based compensation plans as of December 29, 2013 and changes during the three fiscal years ended December 29, 2013 is presented below (in thousands, except for weighted average exercise price and remaining contractual term):
 
Shares
 
Weighted Average Exercise Price
 
Weighted Average Remaining Contractual Term (Years)
 
Aggregate Intrinsic Value
Options and SARs outstanding at January 2, 2011
20,393

 
$
32.18

 
3.8
 
$
393,996

Granted
3,157

 
44.96

 
 
 
 

Exercised
(5,310
)
 
24.81

 
   
 
126,929

Forfeited
(536
)
 
29.09

 
 
 
 

Expired
(354
)
 
51.79

 
 
 
 

Options assumed through acquisition
209

 
4.35

 
 
 
 
Options and SARs outstanding at January 1, 2012
17,559

 
36.55

 
3.4
 
257,251

Granted
2,336

 
46.49

 
 
 
 
Exercised
(3,403
)
 
21.32

 
   
 
81,622

Forfeited
(469
)
 
38.12

 
 
 
 

Expired
(597
)
 
53.10

 
 
 
 

Options and SARs outstanding at December 30, 2012
15,426

 
40.73

 
3.2
 
109,411

Granted
1,142

 
52.69

 
 
 
 
Exercised
(7,362
)
 
35.53

 
   
 
163,992

Forfeited
(433
)
 
43.72

 
 
 
 

Expired
(2,363
)
 
60.70

 
 
 
 

Options assumed through acquisition
183

 
19.37

 
 
 
 
Options and SARs outstanding at December 29, 2013
6,593

 
40.66

 
4.2
 
195,018

Options and SARs vested and expected to vest after December 29, 2013, net of forfeitures
6,291

 
40.31

 
4.1
 
188,288

Options and SARs exercisable at December 29, 2013
3,208

 
33.99

 
3.1
 
116,294
Summary of the changes in RSUs outstanding
A summary of the changes in RSUs outstanding under the Company’s share-based compensation plans during the three fiscal years ended December 29, 2013 is presented below (in thousands, except for weighted average grant date fair value):
 
Shares
 
Weighted Average Grant Date Fair Value
 
Aggregate Intrinsic Value
Non-vested share units at January 2, 2011
1,244

 
$
28.64

 
$
62,007

Granted
1,335

 
47.56

 
 

Vested
(396
)
 
29.63

 
19,309

Forfeited
(132
)
 
37.24

 
 

Non-vested share units at January 1, 2012
2,051

 
40.22

 
100,913

Granted
1,840

 
45.04

 
 

Vested
(646
)
 
47.75

 
29,479

Forfeited
(227
)
 
42.85

 
 

Assumed through acquisition
59

 
46.63

 
 
Non-vested share units at December 30, 2012
3,077

 
43.51

 
131,622

Granted
2,665

 
53.99

 
 

Vested
(950
)
 
41.97

 
50,268

Forfeited
(338
)
 
46.93

 
 

Non-vested share units at December 29, 2013
4,454

 
49.87

 
221,457
Share-based compensation expense
The following tables set forth the detailed allocation of the share-based compensation expense (in thousands):
 
Fiscal years ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Share-based compensation expense by caption:
 
 
 
 
 
Cost of revenue
$
9,820

 
$
7,459

 
$
4,674

Research and development
51,521

 
41,009

 
34,202

Sales and marketing
19,193

 
14,585

 
10,593

General and administrative
19,222

 
15,390

 
13,641

Total share-based compensation expense
99,756

 
78,443

 
63,110

Total tax benefit recognized
(28,183
)
 
(20,122
)
 
(17,008
)
Decrease in net income
$
71,573

 
$
58,321

 
$
46,102

 
 
 
 
 
 
Share-based compensation expense by type of award:
 
 
 
 
 
Stock options and SARs
$
32,803

 
$
35,428

 
$
33,684

RSUs
59,962

 
35,260

 
22,355

ESPP
6,991

 
7,755

 
7,071

Total share-based compensation expense
99,756

 
78,443

 
63,110

Total tax benefit recognized
(28,183
)
 
(20,122
)
 
(17,008
)
Decrease in net income
$
71,573

 
$
58,321

 
$
46,102
Fair value of options and RSUs
The total grant date fair value of options and RSUs vested during the three fiscal years ended December 29, 2013 was as follows (in thousands):
 
Fiscal years ended
 
December 29,
2013
 
December 30,
2012
 
January 1,
2012
Fair value of options vested
$
36,703

 
$
37,674

 
$
33,868

Fair value of RSUs vested
39,885

 
24,327

 
11,747

Total fair value of options and RSUs vested
$
76,588

 
$
62,001

 
$
45,615